Karen Akinsanya

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Nautilus Biotechnology Inc., 3 years.

3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 17, 2026 Schrodinger Inc. Option exercise +31,599 $4.34 $137,140
Sep 17, 2026 Schrodinger Inc. Open-market sale −10,000 $28.00 $280,000
Sep 17, 2026 Schrodinger Inc. Open-market sale −21,599 $30.00 $647,970
Mar 5, 2026 Schrodinger Inc. Open-market sale −1,366 $12.90 $17,621
Mar 2, 2026 Schrodinger Inc. Grant or award +24,250 — —
Mar 2, 2026 Schrodinger Inc. Grant or award +6,077 — —
Mar 2, 2026 Schrodinger Inc. Grant or award +27,576 — —
Mar 2, 2026 Schrodinger Inc. Open-market sale −2,206 $11.99 $26,450
Apr 14, 2025 Schrodinger Inc. Option exercise +13,378 $3.22 $43,077
Apr 14, 2025 Schrodinger Inc. Option exercise +3,345 $2.92 $9,767
Apr 14, 2025 Schrodinger Inc. Open-market sale −8,378 $25.11 $210,372
Apr 14, 2025 Schrodinger Inc. Open-market sale −5,000 $25.11 $125,550
Apr 14, 2025 Schrodinger Inc. Open-market sale −3,345 $25.00 $83,625
Mar 3, 2025 Schrodinger Inc. Grant or award +15,625 — —

Questions about Karen Akinsanya

What boards is Karen Akinsanya on?

Karen Akinsanya sits on the board of Nautilus Biotechnology Inc.

How long has Karen Akinsanya served on boards?

Our records show at least 3 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.